| Members |
targetComponentId |
| patient avböjer hormonersättningsbehandling |
Hormone replacement therapy declined |
| patient undersökt |
Patient review (procedure) |
| Patient reviewed |
Patient review (procedure) |
| Patient reviewed at hospital |
Review at hospital (procedure) |
| patient undersökt på sjukhus |
Review at hospital (procedure) |
| av patienten skrivet förlossningsbrev |
Patient written birth plan (record artifact) |
| oligoartikulär juvenil reumatoid artrit |
Juvenile idiopathic arthritis, oligoarthritis (disorder) |
| Pauciarticular onset juvenile chronic arthritis |
Juvenile idiopathic arthritis, oligoarthritis (disorder) |
| fridfull miljö |
Peaceful environment (finding) |
| persika, livsmedel |
Peach (substance) |
| jordnötter, livsmedel |
Peanut (substance) |
| päron, livsmedel |
Pear (substance) |
| Pectobacterium chrysanthemi |
Dickeya chrysanthemi (organism) |
| stjälkad tvärgående musculus rectus abdominis-lambå |
Pedicle transverse rectus abdominis myocutaneous flap (substance) |
| Pediculus humanus humanus |
Pediculus humanus |
| Pediococcus urinae-equi |
Aerococcus urinaeequi (organism) |
| pegaptanid 0,3 mg, intravitreal injektionsvätska, lösning, förfylld spruta 1 ml |
Pegaptanib (as pegaptanib sodium) 3.33 mg/mL solution for injection |
| peginterferon alfa-2a 135 mikrogram, injektionsvätska, lösning, förfylld spruta 0,5 ml |
Product containing precisely interferon alfa-2a (as peginterferon alfa-2a) 270 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| peginterferon alfa-2a 180 mikrogram, injektionsvätska, lösning, förfylld spruta 0,5 ml |
Interferon alfa-2a (as peginterferon alfa-2a) 360 microgram/mL solution for injection |
| peginterferon alfa-2b 100 mikrogram, pulver och vätska till injektionslösning, flaska |
Interferon alfa-2b (as peginterferon alfa-2b) 100 microgram powder for solution for injection vial |
| peginterferon alfa-2b 100 mikrogram, pulver till injektionsvätska, lösning, förfylld penna |
Peginterferon alfa-2b only product in parenteral dose form |
| peginterferon alfa-2b 100 mikrogram, pulver och vätska till injektionslösning, förfylld penna |
Peginterferon alfa-2b only product in parenteral dose form |
| peginterferon alfa-2b 120 mikrogram, pulver och vätska till injektionslösning, flaska |
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 120 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
| peginterferon alfa-2b 120 mikrogram, pulver och vätska till injektionslösning, förfylld penna |
Interferon alfa-2b (as peginterferon alfa-2b) 120 microgram powder for solution for injection pen |
| peginterferon alfa-2b 150 mikrogram, pulver och vätska till injektionslösning, flaska |
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 150 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
| peginterferon alfa-2b 150 mikrogram, pulver och vätska till injektionsvätska, lösning, förfylld penna |
Interferon alfa-2b (as peginterferon alfa-2b) 150 microgram powder for solution for injection pen |
| peginterferon alfa-2b 50 mikrogram, pulver och vätska till injektionslösning, flaska |
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 50 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
| peginterferon alfa-2b 50 mikrogram, pulver och vätska till injektionslösning, förfylld penna |
Interferon alfa-2b (as peginterferon alfa-2b) 50 microgram powder for solution for injection pen |
| peginterferon alfa-2b 80 mikrogram, pulver och vätska till injektionslösning, flaska |
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 80 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
| peginterferon alfa-2b 80 mikrogram, pulver och vätska till injektionslösning, förfylld penna |
Interferon alfa-2b (as peginterferon alfa-2b) 80 microgram powder for solution for injection pen |
| Pegvisomant 30mg powder for injection solution vial |
Pegvisomant 20 mg powder for solution for injection vial |
| somatisk dysfunktion i bäckenet |
Somatic dysfunction |
| Penicillin G benzathine 300,000unit/mL injection |
Product containing precisely benzathine benzylpenicillin 300000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| bensylpenicillin, bensatin 1 200 000 enheter/2 ml, suspension |
Product containing only benzylpenicillin (medicinal product) |
| bensylpenicillin, bensatin 150 000 IE och bensylpenicillin, prokain 150 000 IE, pulver till injektinsvätska, lösning, flaska |
Product containing precisely benzathine benzylpenicillin 150000 unit/1 milliliter and procaine benzylpenicillin 150000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| Penicillin g benzathine 300,000unt/mL injection |
Product containing precisely benzathine benzylpenicillin 300000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| bensylpenicillin, bensatin 300 000 enheter/ml, injektionsvätska, suspension, flaska 10 ml |
Product containing precisely benzathine benzylpenicillin 300000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| bensylpenicillin, bensatin 300 000 enheter/ml, injektionsvätska, suspension, flaska 1 ml |
Product containing precisely benzathine benzylpenicillin 300000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| bensylpenicillin, bensatin 600 000 enheter/ml, injektionsvätska, suspension, flaska 1 ml |
Benzathine benzylpenicillin 600000 unit/mL suspension for injection |
| bensylpenicillin, bensatin 600 000 enheter/ml, injektionsvätska, suspension, flaska 20 ml |
Benzathine benzylpenicillin 600000 unit/mL suspension for injection |
| bensylpenicillin, bensatin 600 000 enheter/ml, injektionsvätska, suspension, flaska 2 ml |
Benzathine benzylpenicillin 600000 unit/mL suspension for injection |
| bensylpenicillin, bensatin 600 000 enheter/ml, injektionsvätska, suspension, flaska 4 ml |
Benzathine benzylpenicillin 600000 unit/mL suspension for injection |
| bensylpenicillin, bensatin 900 000 IE och bensylpenicillin, prokain 300 000 IE, pulver till injektionsvätska, flaska |
Benzathine benzylpenicillin 900000 unit/mL and procaine benzylpenicillin 300000 unit/mL suspension for injection |
| bensylpenicillin, prokain 600 000 enheter/ml, injektionsvätska, suspension, flaska 1 ml |
Product containing precisely procaine benzylpenicillin 600000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| bensylpenicillin, prokain 600 000 enheter/ml, injektionsvätska, suspension, flaska 4 ml |
Product containing precisely procaine benzylpenicillin 600000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| överdos av penicillin |
Penicillin antibacterial overdose (disorder) |
| Penicillium mycetogenum |
Penicillium mycetomagenum |
| Penicillium patulum |
Penicillium griseofulvum |
| Penicillium rubrum |
Talaromyces purpureogenus (organism) |
| Penicillium rubrum toxicosis |
Penicillium purpurogenum toxicosis (disorder) |
| penicilloyl G-extrakt |
Product containing benzylpenicillin (medicinal product) |
| penicilloyl V-extrakt |
Phenoxymethylpenicillin-containing product |
| Pentamidine isethionate 300mg injection |
Pentamidine isetionate 300 mg powder for solution for injection vial |
| pentamidinisetionat 300 mg/5 ml, lösning för nebulisator |
Product containing precisely pentamidine isethionate 60 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
| Pentamidine isethionate 300mg/vial injection |
Pentamidine isetionate 300 mg powder for solution for injection vial |
| Pentasa 1g/100mL retention enema |
Mesalazine only product in rectal dose form |
| pentastärkelse 10 %, infusionsvätska, lösning, flaska |
Pentastarch 100 mg/mL solution for injection |
| pentastärkelse 10 %, injektionsvätska, lösning, påse |
Pentastarch 100 mg/mL solution for injection |
| pentastärkelse 10 g/100 ml, infusionsvätska, lösning, påse 500 ml |
Pentastarch 100 mg/mL solution for injection |
| Pentastarch 10g/100mL injection |
Pentastarch 100 mg/mL solution for injection |
| pentastärkelse 10 g/100 ml, intravenös vätska, lösning, påse 500 ml |
Pentastarch 100 mg/mL solution for injection |
| pentastärkelse 6 % i natriumklorid 7,2 %, injektionsvätska, lösning |
Product containing only pentastarch (medicinal product) |
| pentastärkelse 6 % i natriumklorid 7,2 %, intravenös infusionsvätska |
Product containing only pentastarch (medicinal product) |
| pentastärkelse 6 %, infusionsvätska, lösning, flaska |
Product containing precisely pentastarch 60 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| pentastarchallergi |
Non-allergic hypersensitivity to pentastarch |
| pentobarbitalnatrium 18,2 mg/5 ml, elixir |
Product containing precisely pentobarbital sodium 3.64 milligram/1 milliliter conventional release oral solution (clinical drug) |
| pentobarbitalnatrium 20 mg/5 ml, elixir |
Pentobarbital sodium 4 mg/mL oral solution |
| Pentose shunt pathway |
Pentose shunt pathway |
| Pentostatin 10mg injection |
Pentostatin 10 mg powder for solution for injection vial |
| Pentosyltransferase |
Pentosyltransferase |
| pepsinspecifikt extrakt |
Product containing pepsin A (medicinal product) |
| peptisk refluxsjukdom |
Gastro-esophageal reflux disease with esophagitis |
| Peptide hydrolase |
Peptide hydrolase |
| Peptostreptococcus hydrogenalis |
Anaerococcus hydrogenalis (organism) |
| Peptostreptococcus lactolyticus |
Anaerococcus lactolyticus (organism) |
| Peptostreptococcus magnus |
Finegoldia magna (organism) |
| Peptostreptococcus octavius |
Anaerococcus octavius (organism) |
| Peptostreptococcus parvulus |
Lancefieldella parvula |
| Peptostreptococcus prevotii |
Anaerococcus prevotii (organism) |
| Peptostreptococcus productus |
Blautia producta |
| Peptostreptococcus tetradius |
Anaerococcus tretradius (organism) |
| Peptostreptococcus vaginalis |
Anaerococcus vaginalis (organism) |
| perkussionsvibratorteknik |
Osteopathic combined treatment method (procedure) |
| perfluoroalkylpolyeter 50 % + polytetrafluoroetylen 50 %, pasta för lokalt bruk |
Perfluoroalkylpolyether and polytetrafluoroethylene only product |
| perflutren 2 ml, lösning i flaska |
Perflutren only product |
| perforation av rotkanal orsakad av endodontisk behandling |
Perforation of root canal wall due to endodontic procedure |
| Pergolide 0.05mg tablet |
Product containing precisely pergolide (as pergolide mesilate) 50 microgram/1 each conventional release oral tablet (clinical drug) |
| Pergolide 0.25mg tablet |
Pergolide (as pergolide mesilate) 250 microgram oral tablet |
| Pergolide 1000micrograms tablet |
Product containing precisely pergolide (as pergolide mesilate) 1 milligram/1 each conventional release oral tablet (clinical drug) |
| Pergolide mesylate 0.05mg tablet |
Product containing precisely pergolide (as pergolide mesilate) 50 microgram/1 each conventional release oral tablet (clinical drug) |
| Pergolide mesylate 0.25mg |
Pergolide (as pergolide mesilate) 250 microgram oral tablet |
| Perifolliculitis of the scalp |
Perifolliculitis capitis abscedens et suffodiens |
| perinatal kvävning |
Asphyxiation |
| perindoprilallergi |
Non-allergic hypersensitivity to perindopril (finding) |
| Perineural neurolysis |
Destruction - action |
| Periodic |
Periodic |
| parodontit i samband med kronisk familjär neutropeni |
Periodontitis exacerbated by chronic familial neutropenia |
| periodontit i samband med cyklisk neutropeni |
Periodontitis exacerbated by cyclical neutropenia (disorder) |
| parodontit samtidigt med Chédiak-Higashis syndrom |
Periodontitis exacerbated by Chédiak-Higashi syndrome (disorder) |
| parodontit samtidigt med Cohens syndrom |
Periodontitis exacerbated by Cohen syndrome |
| parodontit samtidigt med Downs syndrom |
Periodontitis exacerbated by Down syndrome |